Mina S. Ally

Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma

Scott X. Atwood, Kavita Y. Sarin, Ramon J. Whitson et al. · Cancer Cell · 2015 · 415 citations · Full text

Oncology, Health Sciences, Somatic Variant +12

An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma

Mina S. Ally, Sumaira Z. Aasi, Ashley Wysong et al. · Journal of the American Academy of Dermatology · 2014 · 141 citations

Surgical Oncology, Medicine, Dermatological Surgery +6

Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Jean Y. Tang, Mina S. Ally, Anita M. Chanana et al. · The Lancet Oncology · 2016 · 134 citations

Medicine, Basal-cell Nevus Syndrome, Clinical Trials +10

Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma

Mina S. Ally, Katherine J. Ransohoff, Kavita Y. Sarin et al. · JAMA Dermatology · 2016 · 89 citations · Full text

Indolent <scp>CD8⁺</scp> lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features

Danielle Greenblatt, Mina S. Ally, Fiona Child et al. · Journal of Cutaneous Pathology · 2012 · 77 citations